MassDevice article, page-3

First 3 Last

Share
Profile

Follow
Inquisitve1

1,380 Posts.

184

01/07/17

07:44

Post #: 25603326
Share

Originally posted by Eire2011 ↑

This is a must read article for all Admedus holders and potential holders.

Here is an extract from Wayne:

“We were able to marshal together quite a few engineers who had worked on currently marketed TAVR’s – people who had previously been employees at some of those companies,” Paterson said. “It’s the only city where you can actually assemble 4, 5 or 6 of these guys together and say, “What can we do here?”

With the team assembled, the project has “progressed quite significantly,” Paterson said. With the tissue development already done, the group has a leg-up on the process, with a working prototype already assembled alongside a wealth of IP related to the device.

“They’ve built a better mouse trap, for want of a better term. Clearly one that won’t calcify. We’re in a bit of a perfect storm right now,” Paterson said. “When I have a decent amount of IP lodged, I will then be looking to talk to 1 or 2 of the big 4, to look to a co-development deal.”

10% of this market is worth over $500 million and two companies currently hold 80% market share. The other big boys will want a piece of the pie. It's a perfect storm for us!

Yes, it's blue sky for sure but bluer and closer to earth than Immunotherapies.

Furthermore, a zero chance of success is in our current valuation and I think we have a much better chance than zero.

Exciting times ahead.

Expand

To me this also makes ahz rare- substantial revenues and growth and excitement and buzz of what they may still achieve and the blue sky opportunity

AHZ Price at posting: 26.5¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

LKY

Locksley Resources the latest speccy to surge on US critical minerals hype

WIN

'Incorrect datasets': Old irony sets WIN Metals up for golden opportunity at Emjay

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

AII

Inside the depths of Panasqueira: A legacy carved in rock

Tuesday's HotCopper trends: Sayona intercepts, Bowen Coking crisis | July 15

First 3 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $4.97		Change -0.060(1.19%)		Mkt cap ! $78.29M

Open	High	Low	Value	Volume
$4.94	$5.18	$4.92	$78.56K	15.72K

Buyers (Bids)

No.	Vol.	Price($)
1	700	$4.95

Sellers (Offers)

Price($)	Vol.	No.
$4.98	100	1

View Market Depth

No.	Vol.	Price($)
1	700	4.950
1	202	4.930
1	18576	4.920
3	1804	4.900
2	705	4.850

Price($)	Vol.	No.
4.980	100	1
5.000	100	1
5.090	2295	2
5.100	1100	2
5.200	1040	1

Last trade - 15.26pm 15/07/2025 (20 minute delay)

AVR (ASX) Chart

MassDevice article, page-3

Locksley Resources the latest speccy to surge on US critical minerals hype

'Incorrect datasets': Old irony sets WIN Metals up for golden opportunity at Emjay

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Inside the depths of Panasqueira: A legacy carved in rock

Tuesday's HotCopper trends: Sayona intercepts, Bowen Coking crisis | July 15

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MassDevice article, page-3

Top Stories

Locksley Resources the latest speccy to surge on US critical minerals hype

'Incorrect datasets': Old irony sets WIN Metals up for golden opportunity at Emjay

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Inside the depths of Panasqueira: A legacy carved in rock

Tuesday's HotCopper trends: Sayona intercepts, Bowen Coking crisis | July 15

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News